Class III Phosphatidylinositol 4-Kinase Alpha and Beta Are Novel Host Factor Regulators of Hepatitis C Virus Replication
about
The lipid kinase phosphatidylinositol-4 kinase III alpha regulates the phosphorylation status of hepatitis C virus NS5AAnnexin A2 is involved in the formation of hepatitis C virus replication complex on the lipid raftRecruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartmentHepatitis C virus NS5A protein interacts with phosphatidylinositol 4-kinase type IIIalpha and regulates viral propagationSystems virology identifies a mitochondrial fatty acid oxidation enzyme, dodecenoyl coenzyme A delta isomerase, required for hepatitis C virus replication and likely pathogenesisMechanisms of Cellular Membrane Reorganization to Support Hepatitis C Virus ReplicationHost-Targeting Agents to Prevent and Cure Hepatitis C Virus InfectionCuring a viral infection by targeting the host: the example of cyclophilin inhibitorsAutophagy in hepatitis C virus-host interactions: potential roles and therapeutic targets for liver-associated diseasesPhosphoinositides: tiny lipids with giant impact on cell regulationMolecular determinants and dynamics of hepatitis C virus secretionIncreased susceptibility of Huh7 cells to HCV replication does not require mutations in RIG-IDesign and Structural Characterization of Potent and Selective Inhibitors of Phosphatidylinositol 4 Kinase IIIβElucidating novel hepatitis C virus-host interactions using combined mass spectrometry and functional genomics approachesA combined proteomics/genomics approach links hepatitis C virus infection with nonsense-mediated mRNA decayPlasticity of PI4KIIIα interactions at the plasma membranePtdIns4P synthesis by PI4KIIIα at the plasma membrane and its impact on plasma membrane identityPhosphatidylinositol 4-kinases: hostages harnessed to build panviral replication platformsViral reorganization of the secretory pathway generates distinct organelles for RNA replication.Cinderella story: PI4P goes from precursor to key signaling moleculeMetabolism of phosphatidylinositol 4-kinase IIIα-dependent PI4P Is subverted by HCV and is targeted by a 4-anilino quinazoline with antiviral activityHepatitis C virus replication and Golgi function in brefeldin a-resistant hepatoma-derived cellsHepatitis C virus triggers Golgi fragmentation and autophagy through the immunity-related GTPase M.Replication vesicles are load- and choke-points in the hepatitis C virus lifecycle.A major determinant of cyclophilin dependence and cyclosporine susceptibility of hepatitis C virus identified by a genetic approachRab18 facilitates dengue virus infection by targeting fatty acid synthase to sites of viral replicationInvolvement of hepatitis C virus NS5A hyperphosphorylation mediated by casein kinase I-α in infectious virus production.Glycogen synthase kinase 3β inhibitors prevent hepatitis C virus release/assembly through perturbation of lipid metabolismIntegrative functional genomics of hepatitis C virus infection identifies host dependencies in complete viral replication cyclec-Fos regulates hepatitis C virus propagation.Dengue virus-induced autophagy regulates lipid metabolismWest Nile virus replication requires fatty acid synthesis but is independent on phosphatidylinositol-4-phosphate lipidsThe role of the phosphatidylinositol 4-kinase PI4KA in hepatitis C virus-induced host membrane rearrangement.Normalizing for individual cell population context in the analysis of high-content cellular screens.ARF1 and GBF1 generate a PI4P-enriched environment supportive of hepatitis C virus replication.Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral replication and increases cellular fatty acid synthesis.The dependence of viral RNA replication on co-opted host factors.Barriers of hepatitis C virus interspecies transmissionSelf-enhancement of hepatitis C virus replication by promotion of specific sphingolipid biosynthesis.Phosphatidylinositol 4-kinase III beta is a target of enviroxime-like compounds for antipoliovirus activity.
P2860
Q21131379-F7F8E743-33C5-4CDE-AE2C-69A1F2E2437FQ24304279-CDFF64DC-2AC4-45FA-8AFD-8788BE0DD1A5Q24337128-4476C350-CD44-4DA8-97F5-6B07AEFC181FQ24339370-40B437D5-2931-4FD4-B4D0-879523771322Q24631218-31E0441B-8945-4C52-82CC-1C13001E4182Q26746922-D316B9D0-E7CF-408A-8FA2-32BFAC4B7F8BQ26779128-461D0BC8-34C9-47C6-8FF8-045A74AFFFF6Q26828727-D8CE5DB5-F79A-42E3-9878-9408BB2D3E88Q26992256-73C79B74-4178-4770-B5B7-461AFBB8D48DQ27012953-1B03572A-176D-4F0F-88A0-C6C14992E7B3Q27347838-F7DCF436-E92A-4356-94FB-92BAA0F718B5Q27491012-D1255635-E00B-4A33-BF9F-930878EB6A24Q27704036-A2D9D4AD-56A9-4CD2-AA18-CEBBF26A7734Q28115639-A6B1D411-1466-459F-9574-8A23891CA460Q28115899-A45D5E9E-BAB4-4B9C-83FD-FE2F55DD8295Q28116252-66A6967B-BF1F-42E2-9E01-F86F3473C580Q28118990-E9E84270-1A0B-421A-AF70-DF80FD626BB5Q28267464-0704A50D-DC16-4E76-9D61-8F04B2092E59Q28283814-6B602C76-C7D8-40D3-B794-C4A787D65004Q28301748-36F1104F-D630-4FB5-BF7F-C3E708DB5013Q28481438-E1605E7E-D555-41DD-809D-1B4D8AD090C0Q28533615-C76A96D5-3EDC-4B77-B2C2-467F7FD8038AQ29871458-52715E0A-C83F-4577-985C-D864F90851C9Q31129723-C5780774-D26C-40D3-9EED-77CE8523171FQ33707739-9E82C5C3-E44C-4181-AA31-7D84B2584185Q33743801-EB1D86B3-95F8-4B7C-9563-E6998FCDB378Q33744016-8EDFCCDB-EA8F-4B3A-9DE9-5A8AABB38E9EQ33747040-26481AC0-7ED0-482F-AC9E-9414D8D7F6BBQ33893794-01B8EC99-6EA1-47C0-B908-1D7AA50BBD69Q34020208-13405E2A-0AF2-4619-8ABB-626D473F7194Q34024721-27FB7C15-605E-4437-84FE-C7B58397753CQ34031714-7FF5AC43-2D4C-417D-9330-DBC53FF00986Q34056249-9DADFC13-15E5-4EDC-B3BB-1BC14EFF3376Q34106636-99DCE068-728E-4996-89BD-52780FE866B6Q34168582-76950BFB-38A5-485B-A4D4-1EAEBAD098EAQ34182803-56D59E37-6374-4B65-BC6C-C48B1C4654DEQ34241671-F5F8F952-01F3-4ABC-BFEC-BA905F881673Q34315915-65DE6C6D-8CA2-49CD-876D-38B455A4EE10Q34390521-1F755A78-EC84-457C-872C-1C977AC8A26EQ34742005-CF7D298B-5F24-413A-B034-E4030C7C8E09
P2860
Class III Phosphatidylinositol 4-Kinase Alpha and Beta Are Novel Host Factor Regulators of Hepatitis C Virus Replication
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Class III Phosphatidylinositol ...... Hepatitis C Virus Replication
@ast
Class III Phosphatidylinositol ...... Hepatitis C Virus Replication
@en
Class III Phosphatidylinositol ...... Hepatitis C Virus Replication
@nl
type
label
Class III Phosphatidylinositol ...... Hepatitis C Virus Replication
@ast
Class III Phosphatidylinositol ...... Hepatitis C Virus Replication
@en
Class III Phosphatidylinositol ...... Hepatitis C Virus Replication
@nl
prefLabel
Class III Phosphatidylinositol ...... Hepatitis C Virus Replication
@ast
Class III Phosphatidylinositol ...... Hepatitis C Virus Replication
@en
Class III Phosphatidylinositol ...... Hepatitis C Virus Replication
@nl
P2093
P2860
P3181
P356
P1433
P1476
Class III Phosphatidylinositol ...... Hepatitis C Virus Replication
@en
P2093
Brigitte Wiedmann
Christopher J Wilson
Craig Mickanin
Gerard Joberty
Ivan Cornellataracido
Jason Borawski
Jeremy Baryza
Joanna E Mathy
John Tallarico
Juliet Leighton-Davies
P2860
P304
P3181
P356
10.1128/JVI.02418-08
P577
2009-10-01T00:00:00Z